Abstract
A simple and sensitive red spectrofluorimetric method has been described for the estimation of hypocrellin B in rabbit plasma and ocular tissues such as retina, iris, aqueous humour and vitreous body. The fluorimetric estimation was achieved using black coloured 96- well plate at an excitation/emission wavelengths of 470/620 nm with a specific well volume of 100 µL/well. Hypocrellin B calibration curves were linear at a concentration ranging from 20 ng/mL to 1280 ng/mL with correlation coefficient between 0.86 and 0.99 in ocular tissues and plasma. Limit of detection and quantification was between 0.011 to 0.017 µg/mL and 0.034 to 0.054 g/mL respectively for hypocrellin B in different ocular tissues and plasma. The percentage relative standard deviation observed for the validation parameters such as method precision, system precision, intra- inter day, analyst to analyst variations and robustness is found to be less than 12.5 % for the observed fluorescence intensity in different ocular tissues/plasma. The method has been applied to check the hypocrellin B concentration in plasma and ocular tissues after intravenous administration and found that hypocrellin B has some exposure to the posterior segment of eye without major intraocular presuure abnormalities. This selective and sensitive fluorimetric method will facilitate the future investigations of hypocrellin B on ocular delivery of hypocrellin B with less solvent consumption.
Keywords: Calibration, emission, excitation, eye, fluorimetric, hypocrellin B.
Current Bioactive Compounds
Title:Quantification of Hypocrellin B in Rabbit Ocular Tissues/Plasma by Spectrofluorimeter: Application to Biodistribution Study
Volume: 10 Issue: 4
Author(s): Venkateshwaran Krishnaswami, Chandrasekar Ponnusamy, Senthilkumar Sankareswaran, Muthuselvam Paulsamy, Rajaguru Palanisamy and Subramanian Natesan
Affiliation:
Keywords: Calibration, emission, excitation, eye, fluorimetric, hypocrellin B.
Abstract: A simple and sensitive red spectrofluorimetric method has been described for the estimation of hypocrellin B in rabbit plasma and ocular tissues such as retina, iris, aqueous humour and vitreous body. The fluorimetric estimation was achieved using black coloured 96- well plate at an excitation/emission wavelengths of 470/620 nm with a specific well volume of 100 µL/well. Hypocrellin B calibration curves were linear at a concentration ranging from 20 ng/mL to 1280 ng/mL with correlation coefficient between 0.86 and 0.99 in ocular tissues and plasma. Limit of detection and quantification was between 0.011 to 0.017 µg/mL and 0.034 to 0.054 g/mL respectively for hypocrellin B in different ocular tissues and plasma. The percentage relative standard deviation observed for the validation parameters such as method precision, system precision, intra- inter day, analyst to analyst variations and robustness is found to be less than 12.5 % for the observed fluorescence intensity in different ocular tissues/plasma. The method has been applied to check the hypocrellin B concentration in plasma and ocular tissues after intravenous administration and found that hypocrellin B has some exposure to the posterior segment of eye without major intraocular presuure abnormalities. This selective and sensitive fluorimetric method will facilitate the future investigations of hypocrellin B on ocular delivery of hypocrellin B with less solvent consumption.
Export Options
About this article
Cite this article as:
Krishnaswami Venkateshwaran, Ponnusamy Chandrasekar, Sankareswaran Senthilkumar, Paulsamy Muthuselvam, Palanisamy Rajaguru and Natesan Subramanian, Quantification of Hypocrellin B in Rabbit Ocular Tissues/Plasma by Spectrofluorimeter: Application to Biodistribution Study, Current Bioactive Compounds 2014; 10 (4) . https://dx.doi.org/10.2174/1573407210666141001000336
DOI https://dx.doi.org/10.2174/1573407210666141001000336 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HDL and Inflammation in Atherosclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Critical Congenital Heart Disease in Neonates: A Review Article
Current Pediatric Reviews Biological Nitration of Arachidonic Acid
Current Vascular Pharmacology Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design Non-Invasive Methods and Techniques for Central Blood Pressure Estimation: Procedures, Validation, Reproducibility and Limitations
Current Pharmaceutical Design One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology Structure-Based Rational Design of Adenosine Receptor Ligands
Current Topics in Medicinal Chemistry The NPC1L1 Inhibitor Ezetimibe in the Treatment of the Dyslipidemia in Patients Affected by the Metabolic Syndrome: Evidences and Perspectives
Current Enzyme Inhibition Memantine: A Therapeutic Approach in Treating Alzheimers and Vascular Dementia
Current Drug Targets - CNS & Neurological Disorders microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?
Current Pharmaceutical Design Uremia, Atherothrombosis and Malnutrition: The Role of L-arginine- Nitric Oxide Pathway
Cardiovascular & Hematological Disorders-Drug Targets Hypertension: Basics Concepts and the Evolving Role of Novel Treatments
Current Hypertension Reviews Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
Current Topics in Medicinal Chemistry Phentermine and Topiramate Extended-Release for the Obesity: New Kids on the Block
Recent Patents on Cardiovascular Drug Discovery What’s Old is New Again – A Review of the Current Evidence of Colchicine in Cardiovascular Medicine
Current Cardiology Reviews Nitric Oxide and Protection against Cardiac Ischemia
Current Pharmaceutical Design Adeno-associated Viral Vectors for Correction of Inborn Errors of Metabolism: Progressing Towards Clinical Application
Current Pharmaceutical Design Adrenomedullin in Cardiovascular Disease: A Useful Biomarker, its Pathological Roles and Therapeutic Application
Current Protein & Peptide Science